Newsroom

Apr 07

First Randomized Trial Comparing Colonoscopy to FIT Suggests Colonoscopy is More Effective than FIT

Multiple randomized controlled trials comparing colonoscopy with the fecal immunochemical test (FIT) are currently in progress around the world.

Mar 17

��, Medchi, & Menocal Practice Team Up to Increase CRC Screening in Maryland

�� teams up with MedChi Network Services, a division of the Maryland State Medical Society (MedChi), and the Menocal Family Practice in Frederick to screen uninsured patients for colorectal cancer (CRC)

Mar 11

United in Blue in Washington, D.C.

�� joined partners all around the country yesterday to contribute to the power of speaking in one voice to promote colorectal cancer awareness.

Mar 04

Evidence-Based Strategies Improve Colonoscopy Bowel Preparation Quality, Performance, and Patient Experience

Three U.S. Gastroenterology Societies Jointly Publish Updated Consensus Recommendations

Feb 25

33 Patient and Medical Professional Organizations File Amicus Brief Urging the US Supreme Court to Protect Lifesaving Preventive Care Without Patient Cost Sharing

Today, 33 organizations representing millions of patients with serious health conditions and thousands of health care professionals filed an amicus brief in the U.S. Supreme Court case Braidwood Management v. Kennedy.

Feb 03

Nomination Period Opens for Key Leadership Programs

The nomination period for the 2025 LEAD and GOLD leadership development programs is officially open.

Dec 23

Congress Adjourns Without Stopping Physician Pay Cut

On December 20, Congress passed a short-term spending bill that does not include relief for physicians from a 2.83 percent Medicare payment cut that will take effect January 1.

Dec 18

�� Efforts Pay Off: Lawmakers Agree to Curb Harmful Physician Pay Cut

Dec 06

�� Joins Fight CRC-Led Initiative to Advance Bold Colorectal Cancer Care Goals

�� has joined the Colorectal Cancer Care Initiative (CRCCI), a multi-stakeholder effort designed by Fight Colorectal Cancer! (Fight CRC) to improve colorectal cancer (CRC) screening, diagnosis and treatment in significant ways.

Nov 22

Success: GI societies push BCBS to rescind proposed biosimilar policy

Blue Cross Blue Shield (BCBS) will not move forward with changes to its medical policy guideline “Infliximab Biosimilar Step Therapy Requirements” (Policy Number RX501.051)